3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2026-09-09

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

This head‑to‑head comparative study, backed by solid and transparent data, unequivocally demonstrates that China‑developed cryoprotectants already possess significant international competitiveness in core performance. This not only reflects Yinfeng's technological prowess but also serves as a compelling testament to China's cryobiomedicine field transitioning from "following" to "running alongside" global leaders—earning international discourse power through scientific evidence.

2026-09-04

Science Fiction Becomes Reality? Scientists Precisely Locate Key Brain Circuit for Animal Hibernation, Marking a Major Step Forward in Artificial Hibernation Research

"This is still a very distant vision, but it is supported by very substantial funding." Although the road ahead is long, this study has laid a critical neuroscientific foundation for humanity to knock on the door of "artificial hibernation."

2026-09-04

Russian Scientists Extract "Brain-Repair Sponge" from Jellyfish, Bringing New Hope for Craniocerebral Injuries

Rodkin noted that this study also converts the environmental problem caused by overpopulation of the Azov Sea brown-rooted jellyfish into a source of modern biomedical materials, achieving "waste-to-wealth." Currently, further research is needed to bring this material to clinical application, but the scientific and technological foundations have been laid. This work was supported by the Russian Science Foundation and is expected to offer new therapeutic options for patients with craniocerebral injuries in the future.

2026-08-28

New Breakthrough in Oocyte Cryopreservation: Magnetically Controlled Hydrogel + Microfluidics Significantly Boosts Survival Rates

To address these challenges, a collaborative team led by Professor Chen Zhongrong from Anhui Medical University, Professor Zhao Gang from the University of Science and Technology of China, and Professor Cheng Yue from Anhui Medical University proposed an innovative solution—integrating a microfluidic chip with magnetically controlled hydrogel microencapsulation technology. This research has been published in the internationally renowned journal Biomaterials.

2026-08-28

Behind the $1.5 Billion Acquisition: Cryopreservation Enters the Era of Precision Engineering

The maturation of this paradigm not only facilitates scalable manufacturing of cell therapies but also establishes methodological foundations for scientific exploration of preserving more complex tissues and even whole organisms.

< 1234...46 >
< 1234...28 >